19 June 2013
Keywords: anesiva, halts, drug, candidate, development, california, usa-based
Article | 22 January 2007
California, USA-based Anesiva says that clinical data from a Phase 1 safety study of product candidate 1207, which was being tested as ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 December 2006
18 June 2013
© 2013 thepharmaletter.com